Skip to Main Content

Author Details

Sanja Glisic
Vinca Institute of Nuclear Sciences, The University of Belgrade
1988
83
19
PMIDPaper TitleJournal TitlePublished Year
36768280In Silico and In Vitro Inhibition of SARS-CoV-2 PL<sup>pro</sup> with Gramicidin D.Int J Mol Sci2023
38001445Correction: Patterns of human and porcine gammaherpesvirus-encoded BILF1 receptor endocytosis.Cell Mol Biol Lett2023
37895584Novel Entropy-Based Phylogenetic Algorithm: A New Approach for Classifying SARS-CoV-2 Variants.Entropy (Basel)2023
37175728In Silico Investigation of Selected Pesticides and Their Determination in Agricultural Products Using QuEChERS Methodology and HPLC-DAD.Int J Mol Sci2023
36722278Inhibition of SARS-CoV-2 M<sup>pro</sup> with Vitamin C, L-Arginine and a Vitamin C/L-Arginine Combination.Front Biosci (Landmark Ed)2023
36810008Patterns of human and porcine gammaherpesvirus-encoded BILF1 receptor endocytosis.Cell Mol Biol Lett2023
35103413Identification of SARS-CoV-2 Papain-like Protease (PLpro) Inhibitors Using Combined Computational Approach.ChemistryOpen2022
35638419Simple Theoretical Criterion for Selection of Natural Compounds with Anti-COVID-19 Activity.Front Biosci (Landmark Ed)2022
35565976In Silico Screening of Natural Compounds for Candidates 5HT6 Receptor Antagonists against Alzheimer's Disease.Molecules2022
32842509Drug Repurposing for Candidate SARS-CoV-2 Main Protease Inhibitors by a Novel <i>In Silico</i> Method.Molecules2020
31730520Retraction of: The Effect of a Gender Difference in the Apolipoprotein E Gene DNA Polymorphism on Serum Lipid Levels in a Serbian Healthy Population.Clin Chem Lab Med2020
32977535Critical Impact of Different Conserved Endoplasmic Retention Motifs and Dopamine Receptor Interacting Proteins (DRIPs) on Intracellular Localization and Trafficking of the D<sub>2</sub> Dopamine Receptor (D<sub>2</sub>-R) Isoforms.Biomolecules2020
32794723Biological Rationale for the Repurposing of BCG Vaccine against SARS-CoV-2.J Proteome Res2020
30972303Virtual Screen for Repurposing of Drugs for Candidate Influenza a M2 Ion-Channel Inhibitors.Front Cell Infect Microbiol2019
31719570Computational design and characterization of nanobody-derived peptides that stabilize the active conformation of the β<sub>2</sub>-adrenergic receptor (β<sub>2</sub>-AR).Sci Rep2019
32108589In vitro anti-influenza activity of in silico repurposed candidate drug cycrimine.Antivir Ther2019
31400708Novel electrophilic amides amenable by the Ugi reaction perturb thioredoxin system via thioredoxin reductase 1 (TrxR1) inhibition: Identification of DVD-445 as a new lead compound for anticancer therapy.Eur J Med Chem2019
30986947Synthesis, In Silico, and In Vitro Evaluation of Anti-Leishmanial Activity of Oxadiazoles and Indolizine Containing Compounds Flagged against Anti-Targets.Molecules2019
30707913Functional characterization of β<sub>2</sub>-adrenergic and insulin receptor heteromers.Neuropharmacology2019
28930583Ibuprofen as a template molecule for drug design against Ebola virus.Front Biosci (Landmark Ed)2018
29584709In Silico Discovery of a Substituted 6-Methoxy-quinalidine with Leishmanicidal Activity in Leishmania infantum.Molecules2018
28529693A simple method for calculation of basic molecular properties of nutrients and their use as a criterion for a healthy diet.F1000Res2017
29184482Identification of Candidate Allosteric Modulators of the M1 Muscarinic Acetylcholine Receptor Which May Improve Vagus Nerve Stimulation in Chronic Tinnitus.Front Neurosci2017
27000565Common molecular mechanism of the hepatic lesion and the cardiac parasympathetic regulation in chronic hepatitis C infection: a critical role for the muscarinic receptor type 3.BMC Bioinformatics2016
32309584Simple Chemoinformatics Criterion Using Electron Donor-Acceptor Molecular Characteristics for Selection of Antibiotics Against Multi-Drug-Resistant Bacteria.Discoveries (Craiova)2016
27604469An expanded evaluation of protein function prediction methods shows an improvement in accuracy.Genome Biol2016
27828989Predicted Enhanced Human Propensity of Current Avian-Like H1N1 Swine Influenza Virus from China.PLoS One2016
27208030Comment on Yang et al. Natural Variation in Interleukin-2 Sensitivity Influences Regulatory T-Cell Frequency and Function in Individuals With Long-standing Type 1 Diabetes. Diabetes 2015;64:3891-3902.Diabetes2016
27265687A combined ligand- and structure-based approach for the identification of rilmenidine-derived compounds which synergize the antitumor effects of doxorubicin.Bioorg Med Chem2016
27164067Arginase Flavonoid Anti-Leishmanial in Silico Inhibitors Flagged against Anti-Targets.Molecules2016
26860912The influence of host factors and sequence variability of the p7 region on the response to pegylated interferon/ribavirin therapy for chronic hepatitis C genotype 1b in patients from Serbia.Arch Virol2016
26834545In silico Therapeutics for Neurogenic Hypertension and Vasovagal Syncope.Front Neurosci2016
25745423In silico analysis suggests interaction between Ebola virus and the extracellular matrix.Front Microbiol2015
26429712Natural Products as Promising Therapeutics for Treatment of Influenza Disease.Curr Pharm Des2015
26733989Evolution of 2014/15 H3N2 Influenza Viruses Circulating in US: Consequences for Vaccine Effectiveness and Possible New Pandemic.Front Microbiol2015
26125997Improving attrition rates in Ebola virus drug discovery.Expert Opin Drug Discov2015
26167272In silico analysis suggests repurposing of ibuprofen for prevention and treatment of EBOLA virus disease.F1000Res2015
25927601Preclinical discovery and development of maraviroc for the treatment of HIV.Expert Opin Drug Discov2015
25717373Virtual screen for repurposing approved and experimental drugs for candidate inhibitors of EBOLA virus infection.F1000Res2015
24783415Natural autoantibodies in healthy neonatals recognizing a peptide derived from the second conserved region of HIV-1 gp120.Vojnosanit Pregl2014
25401701Demonstration of a direct interaction between β2-adrenergic receptor and insulin receptor by BRET and bioinformatics.PLoS One2014
25045818Influenza vaccine as prevention for cardiovascular diseases: possible molecular mechanism.Vaccine2014
22429138Simple and general criterion for "in silico" screening of candidate HIV drugs.Curr Pharm Biotechnol2013
24348198Feature-based classification of amino acid substitutions outside conserved functional protein domains.ScientificWorldJournal2013
23658611Novel phylogenetic algorithm to monitor human tropism in Egyptian H5N1-HPAIV reveals evolution toward efficient human-to-human transmission.PLoS One2013
23167743New in silico and conventional in vitro approaches to advance HIV drug discovery and design.Expert Opin Drug Discov2013
22170451Assessment of hepatitis C virus protein sequences with regard to interferon/ribavirin combination therapy response in patients with HCV genotype 1b.Protein J2012
22563437Interaction between Treg apoptosis pathways, Treg function and HLA risk evolves during type 1 diabetes pathogenesis.PLoS One2012
21449717A bioinformatics approach to identify natural autoantibodies from healthy blood donors' sera reactive with the HCV NS5A-derived peptide by immunoassay.Viral Immunol2011
22647065The role of long-range intermolecular interactions in discovery of new drugs.Expert Opin Drug Discov2011
  • 1 - 50 of 83

Recommended Authors

University of California san francisco
Career Start Year 2015
Number of shared co-authors 0
Anyang Institute of Technology
Career Start Year 2013
Number of shared co-authors 0
National University of Sciences and Technology (NUST)
Career Start Year 2012
Number of shared co-authors 0
Mid and South Essex NHS Foundation Trust
Career Start Year 2009
Number of shared co-authors 0
The University of Queensland
Career Start Year 2008
Number of shared co-authors 2
Institute of Insect Science and Technology, South China Normal University
Career Start Year 2006
Number of shared co-authors 2
Molecular and Cell Biology Research Center, Mazandaran University of Medical Sciences
Career Start Year 2006
Number of shared co-authors 0
King Abdulaziz University (KAU), King Abdulaziz University
Career Start Year 2004
Number of shared co-authors 0
Peking Union Medical College Hospital, Chinese Academy of Medical Sciences
Career Start Year 2003
Number of shared co-authors 0
Universite Paris Saclay
Career Start Year 2002
Number of shared co-authors 0
J. David Gladstone Institutes
Career Start Year 2002
Number of shared co-authors 0
Chongqing Center for Disease Control and Prevention.
Career Start Year 2002
Number of shared co-authors 0
Research Institute for Medical and Health Sciences, University of Sharjah
Career Start Year 2001
Number of shared co-authors 0
University Hospital and University of Lausanne
Career Start Year 2001
Number of shared co-authors 0
Sanjay Gandhi Post Graduate Institute of Medical Sciences
Career Start Year 1999
Number of shared co-authors 48
National Taiwan University
Career Start Year 1999
Number of shared co-authors 0
Institute of Pathogens and Vectors, Dali University
Career Start Year 1998
Number of shared co-authors 0
Dasman Diabetes Institute
Career Start Year 1998
Number of shared co-authors 1
College of Science & Industry Convergence, Ewha Womans University
Career Start Year 1997
Number of shared co-authors 0
F. Hoffmann-La Roche Ltd.
Career Start Year 1997
Number of shared co-authors 0
Pondicherry University
Career Start Year 1997
Number of shared co-authors 1
Ajou University
Career Start Year 1995
Number of shared co-authors 0
Institute of Biomedical Sciences
Career Start Year 1995
Number of shared co-authors 0
Shanghai Institute of Materia Medica, Chinese Academy of Sciences
Career Start Year 1994
Number of shared co-authors 0
The University of Danang-University of Science and Technology
Career Start Year 1993
Number of shared co-authors 2
Institute for Physiology, Charite-University Medicine Berlin
Career Start Year 1990
Number of shared co-authors 0
The Chinese University of Hong Kong
Career Start Year 1979
Number of shared co-authors 0
and Blood Institute, National Institutes of Health
Career Start Year 1978
Number of shared co-authors 1
Vir Biotechnology Inc.
Career Start Year 1977
Number of shared co-authors 0
College of Life Sciences and Biotechnology, Yonsei University
Career Start Year 1962
Number of shared co-authors 0

Collaborators

Institute of Microbiology and Immunology, University of Belgrade
Co-authored papers 35
Heliant Ltd
Co-authored papers 33
Institute of Nuclear Sciences VINCA
Co-authored papers 32
Co-authored papers 16
Vinca Institute of Nuclear Sciences, University of Belgrade
Co-authored papers 5
University of Colorado School of Medicine
Co-authored papers 1
US Department of Energy Joint Genome Institute, Lawrence Berkeley National Laboratory
Co-authored papers 1
ShanghaiTech University
Co-authored papers 1
Temple University
Co-authored papers 1
Royal Holloway University of London
Co-authored papers 1
Universita degli Studi di Milano
Co-authored papers 1
Wellcome Sanger Institute
Co-authored papers 1
Instituto de Genetica Medica y Molecular (INGEMM), Hospital Universitario La Paz
Co-authored papers 1
European Bioinformatics Institute (EMBL-EBI)
Co-authored papers 1
University of Lausanne
Co-authored papers 1
University of Turku
Co-authored papers 1
Imperial College London
Co-authored papers 1
Life Science Institute
Co-authored papers 1
Temple University
Co-authored papers 1
Institute for Research in Biomedicine (IRB)
Co-authored papers 1
University of Calgary
Co-authored papers 1
University of Leicester
Co-authored papers 1
Aarhus University
Co-authored papers 1
Italy Consorzio Interuniversitario Nazionale per l'Informatica
Co-authored papers 1
University College London
Co-authored papers 1
European Bioinformatics Institute
Co-authored papers 1
The Alan Turing Institute
Co-authored papers 1
Technical University of Munich (TUM)
Co-authored papers 1
Istanbul Technical University
Co-authored papers 1
Tel Aviv University
Co-authored papers 1